- Home
- BQ vs XAIR Comparison
BQ vs XAIR Comparison
Compare BQ & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BQ | XAIR |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 10.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BQ | XAIR |
|---|---|---|
| Price | $1.94 | $1.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 113.9K | ★ 21.8M |
| Earning Date | 01-05-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $60,004,214.00 | $5,802,000.00 |
| Revenue This Year | N/A | $127.85 |
| Revenue Next Year | N/A | $165.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $1.62 | $0.67 |
| 52 Week High | $56.10 | $10.40 |
Technical Indicators
Market Signals| Indicator | BQ | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 40.35 | 62.87 |
| Support Level | $1.98 | $0.84 |
| Resistance Level | $2.09 | $2.66 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | 0.05 | 0.14 |
| Stochastic Oscillator | 8.02 | 52.69 |
Price Performance
Historical ComparisonAbout BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.